Literature DB >> 34342353

Suv420 enrichment at the centromere limits Aurora B localization and function.

Conor P Herlihy1, Sabine Hahn1, Nicole M Hermance1, Elizabeth A Crowley1, Amity L Manning1.   

Abstract

Centromere structure and function are defined by the epigenetic modification of histones at centromeric and pericentromeric chromatin. The constitutive heterochromatin found at pericentromeric regions is highly enriched for H3K9me3 and H4K20me3. Although mis-expression of the methyltransferase enzymes that regulate these marks, Suv39 and Suv420, is common in disease, the consequences of such changes are not well understood. Our data show that increased centromere localization of Suv39 and Suv420 suppresses centromere transcription and compromises localization of the mitotic kinase Aurora B, decreasing microtubule dynamics and compromising chromosome alignment and segregation. We find that inhibition of Suv420 methyltransferase activity partially restores Aurora B localization to centromeres and that restoration of the Aurora B-containing chromosomal passenger complex to the centromere is sufficient to suppress mitotic errors that result when Suv420 and H4K20me3 is enriched at centromeres. Consistent with a role for Suv39 and Suv420 in negatively regulating Aurora B, high expression of these enzymes corresponds with increased sensitivity to Aurora kinase inhibition in human cancer cells, suggesting that increased H3K9 and H4K20 methylation may be an underappreciated source of chromosome mis-segregation in cancer. This article has an associated First Person interview with the first author of the paper.
© 2021. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Centromere; Chromosome instability; Mitosis

Mesh:

Substances:

Year:  2021        PMID: 34342353      PMCID: PMC8353524          DOI: 10.1242/jcs.249763

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.235


  107 in total

1.  Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression.

Authors:  D O'Carroll; H Scherthan; A H Peters; S Opravil; A R Haynes; G Laible; S Rea; M Schmid; A Lebersorger; M Jerratsch; L Sattler; M G Mattei; P Denny; S D Brown; D Schweizer; T Jenuwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Aurora B phosphorylates spatially distinct targets to differentially regulate the kinetochore-microtubule interface.

Authors:  Julie P I Welburn; Mathijs Vleugel; Dan Liu; John R Yates; Michael A Lampson; Tatsuo Fukagawa; Iain M Cheeseman
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

3.  Live Cell Imaging to Assess the Dynamics of Metaphase Timing and Cell Fate Following Mitotic Spindle Perturbations.

Authors:  Dayna L Mercadante; Elizabeth A Crowley; Amity L Manning
Journal:  J Vis Exp       Date:  2019-09-20       Impact factor: 1.355

4.  Aneuploidy acts both oncogenically and as a tumor suppressor.

Authors:  Beth A A Weaver; Alain D Silk; Cristina Montagna; Pascal Verdier-Pinard; Don W Cleveland
Journal:  Cancer Cell       Date:  2006-12-28       Impact factor: 31.743

5.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

6.  STAG2 promotes error correction in mitosis by regulating kinetochore-microtubule attachments.

Authors:  Marianna Kleyman; Lilian Kabeche; Duane A Compton
Journal:  J Cell Sci       Date:  2014-07-29       Impact factor: 5.285

7.  Shugoshin-1 balances Aurora B kinase activity via PP2A to promote chromosome bi-orientation.

Authors:  Amanda Meppelink; Lilian Kabeche; Martijn J M Vromans; Duane A Compton; Susanne M A Lens
Journal:  Cell Rep       Date:  2015-04-16       Impact factor: 9.423

8.  Centromere protein B assembles human centromeric alpha-satellite DNA at the 17-bp sequence, CENP-B box.

Authors:  Y Muro; H Masumoto; K Yoda; N Nozaki; M Ohashi; T Okazaki
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

Review 9.  The Aurora B Kinase in Chromosome Bi-Orientation and Spindle Checkpoint Signaling.

Authors:  Veronica Krenn; Andrea Musacchio
Journal:  Front Oncol       Date:  2015-10-16       Impact factor: 6.244

Review 10.  Centromeric and ectopic assembly of CENP-A chromatin in health and cancer: old marks and new tracks.

Authors:  Abhishek Bharadwaj Sharma; Stefan Dimitrov; Ali Hamiche; Eric Van Dyck
Journal:  Nucleic Acids Res       Date:  2019-02-20       Impact factor: 16.971

View more
  2 in total

Review 1.  An emerging role of transcription in chromosome segregation: Ongoing centromeric transcription maintains centromeric cohesion.

Authors:  Yujue Chen; Qian Zhang; Hong Liu
Journal:  Bioessays       Date:  2021-11-10       Impact factor: 4.345

2.  Suppression of Chromosome Instability Limits Acquired Drug Resistance.

Authors:  Elizabeth A Crowley; Nicole M Hermance; Conor P Herlihy; Amity L Manning
Journal:  Mol Cancer Ther       Date:  2022-10-07       Impact factor: 6.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.